🇺🇸 FDA
Patent

US 10000551

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

granted A61KA61K36/00A61K38/1793

Quick answer

US patent 10000551 (Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same) held by Protalix Ltd. expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Protalix Ltd.
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K36/00, A61K38/1793